Access cutting-edge cancer treatment through this clinical trial at a research site in Oklahoma City. Study-provided care at no cost to qualified participants.
Access cancer specialists in Oklahoma City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cancer treatment provided free
This phase I/II trial tests the safety, side effects, and best dose of entinostat and ZEN003694 in treating patients with solid tumors or lymphoma that has spread to other places in the body (advanced) or does not respond to treatment (refractory). Entinostat may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. It is in a class of drugs called histone deacetylase (HDAC) inhibitor. ZEN003694 is an inhibitor of a family of proteins called the bromodomain and
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this cancer clinical trial in Oklahoma City, OK
If you're searching for cancer treatment options in Oklahoma City, OK, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Oklahoma City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.